Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
Crossref DOI link: https://doi.org/10.1007/s00280-014-2501-1
Published Online: 2014-07-26
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xia, Chang
Leon-Ferre, Roberto
Laux, Douglas
Deutsch, Jeremy
Smith, Brian J.
Frees, Melanie
Milhem, Mohammed
License valid from 2014-07-26